Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35062
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMorison, Lottie D-
dc.contributor.authorKennis, Milou G P-
dc.contributor.authorRots, Dmitrijs-
dc.contributor.authorBouman, Arianne-
dc.contributor.authorKummeling, Joost-
dc.contributor.authorPalmer, Elizabeth-
dc.contributor.authorVogel, Adam P-
dc.contributor.authorLiegeois, Frederique-
dc.contributor.authorBrignell, Amanda-
dc.contributor.authorSrivastava, Siddharth-
dc.contributor.authorFrazier, Zoe-
dc.contributor.authorMilnes, Di-
dc.contributor.authorGoel, Himanshu-
dc.contributor.authorAmor, David J-
dc.contributor.authorScheffer, Ingrid E-
dc.contributor.authorKleefstra, Tjitske-
dc.contributor.authorMorgan, Angela T-
dc.date2024-
dc.date.accessioned2024-02-07T04:14:30Z-
dc.date.available2024-02-07T04:14:30Z-
dc.date.issued2024-01-30-
dc.identifier.citationJournal of Medical Genetics 2024-01-30en_US
dc.identifier.issn1468-6244-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/35062-
dc.description.abstractSpeech and language impairments are core features of the neurodevelopmental genetic condition Kleefstra syndrome. Communication has not been systematically examined to guide intervention recommendations. We define the speech, language and cognitive phenotypic spectrum in a large cohort of individuals with Kleefstra syndrome. 103 individuals with Kleefstra syndrome (40 males, median age 9.5 years, range 1-43 years) with pathogenic variants (52 9q34.3 deletions, 50 intragenic variants, 1 balanced translocation) were included. Speech, language and non-verbal communication were assessed. Cognitive, health and neurodevelopmental data were obtained. The cognitive spectrum ranged from average intelligence (12/79, 15%) to severe intellectual disability (12/79, 15%). Language ability also ranged from average intelligence (10/90, 11%) to severe intellectual disability (53/90, 59%). Speech disorders occurred in 48/49 (98%) verbal individuals and even occurred alongside average language and cognition. Developmental regression occurred in 11/80 (14%) individuals across motor, language and psychosocial domains. Communication aids, such as sign and speech-generating devices, were crucial for 61/103 (59%) individuals including those who were minimally verbal, had a speech disorder or following regression. The speech, language and cognitive profile of Kleefstra syndrome is broad, ranging from severe impairment to average ability. Genotype and age do not explain the phenotypic variability. Early access to communication aids may improve communication and quality of life.en_US
dc.language.isoeng-
dc.subjectGenetics, Behavioralen_US
dc.subjectHuman Geneticsen_US
dc.subjectNeurologyen_US
dc.subjectPediatricsen_US
dc.subjectPhenotypeen_US
dc.titleExpanding the phenotype of Kleefstra syndrome: speech, language and cognition in 103 individuals.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleJournal of Medical Geneticsen_US
dc.identifier.affiliationSpeech and Language, Murdoch Children's Research Institute, Parkville, Victoria, Australia.;Department of Audiology and Speech Pathology, The University of Melbourne, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Clinical Genetics, Radboudumc, Nijmegen, Netherlands.en_US
dc.identifier.affiliationSydney Children's Hospital Network, Randwick, New South Wales, Australia.;Discipline of Paediatrics and Child Health, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.en_US
dc.identifier.affiliationDepartment of Audiology and Speech Pathology, The University of Melbourne, Melbourne, Victoria, Australia.;Redenlab, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationGreat Ormond Street Institute of Child Health, University College London, London, UK.en_US
dc.identifier.affiliationDepartment of Paediatrics, Monash University, Clayton, Victoria, Australia.;Department of Developmental Paediatrics, Monash Children's Hospital, Clayton, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.en_US
dc.identifier.affiliationGenetic Health Queensland, Herston, Queensland, Australia.en_US
dc.identifier.affiliationHunter Genetics, Waratah, New South Wales, Australia.en_US
dc.identifier.affiliationSpeech and Language, Murdoch Children's Research Institute, Parkville, Victoria, Australia.;Department of Paediatrics, Royal Children's Hospital, Parkville, Victoria, Australia.en_US
dc.identifier.affiliationMelbourne Brain Centre, Austin Health, Heidelberg, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Clinical Genetics, Radboudumc, Nijmegen, Netherlands.;Department of Clinical Genetics, Erasmus MC, Rotterdam, Netherlands.en_US
dc.identifier.affiliationSpeech and Language, Murdoch Children's Research Institute, Parkville, Victoria, Australia.;Department of Audiology and Speech Pathology, The University of Melbourne, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen_US
dc.identifier.doi10.1136/jmg-2023-109702en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-2822-6522en_US
dc.identifier.orcid0000-0002-3505-2631en_US
dc.identifier.orcid0000-0001-7008-1879en_US
dc.identifier.orcid0000-0003-1147-7405en_US
dc.identifier.pubmedid38290825-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptEpilepsy Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Oct 4, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.